Skip to main content

Clinical Trials for Eosinophilic Asthma

If you're living with eosinophilic asthma and struggling to find effective treatment, clinical trials may offer new possibilities for managing your condition.


    Please provide your contact information only.

    Advancing Asthma Care: Clinical Trial for Eosinophilic Asthma

    Eosinophilic asthma is a rare and severe form of asthma driven by high levels of eosinophils—a type of white blood cell that can cause inflammation in the lungs. This condition often leads to frequent asthma attacks, difficulty breathing, and poor response to standard asthma treatments. People living with eosinophilic asthma may experience persistent eosinophilic asthma symptoms despite using inhalers or steroids.

    How Clinical Trials Can Help

    For those facing limited treatment options, clinical trials offer hope. They explore new therapies that could better manage symptoms and improve quality of life. Lucida Clinical Trials is currently conducting a research study focused on eosinophilic asthma. By participating, eligible individuals may access investigational treatment options while helping advance future care for this challenging condition.

    Eosinophilic Asthma

    Investigating New Approaches for Managing Eosinophilic Asthma

    This study aims to compare the effectiveness of switching to a new treatment versus continuing the current treatment for people with severe asthma that has an eosinophilic component. The focus is on whether the new treatment can help reduce the number of serious asthma flare-ups, or exacerbations, as compared to sticking with the current treatment. Throughout the study, all participants will continue their usual asthma care alongside the study treatment. The goal is to determine if switching treatments offers similar or better results in preventing asthma attacks.

    Eosinophilic Asthma: A Tougher Challenge

    Eosinophilic asthma is a less common but more severe type of asthma. It happens when a certain type of white blood cell, called eosinophils, builds up in the lungs and causes inflammation. This can lead to more frequent and intense asthma symptoms that don’t always respond well to standard treatments like inhalers or steroids.

    In the U.S., about 25.7 million people have asthma. Of those, around 15% have a severe form that’s hard to control. Eosinophilic asthma is one of the main causes of severe asthma—affecting more than half of people with this serious condition.

    Taking the Next Step in Asthma Treatment Research

    Lucida Clinical Trials is currently conducting a study focused on eosinophilic asthma. This clinical trial explores whether switching from your current asthma medication to a new treatment can help reduce the number of serious asthma attacks. If you’re eligible, you may gain access to investigational treatment options while also helping researchers discover better ways to manage this challenging condition for others in the future.

    Age:

    12 Years and Older

    Location:

    New Bedford, MA

    Gender:

    Both

    Status:

    Not Recruiting

    Condition:

    Asthma

    Frequently Asked Questions

    Who can join this clinical trial?

    Individuals aged 12 and older with eosinophilic asthma who are currently using asthma medications may be eligible to participate.

    What are the potential benefits of participating?

    You may gain early access to advanced treatment options and receive care from experienced research professionals.

    Is there any cost to take part in the study?

    No. Participation is free, and eligible individuals may receive compensation for time and travel.

    Get Involved in Our Clinical Trials Today

    Join us in advancing medical research and discover new treatment options that could improve your health and well-being.

    Contact Us Today
    Testimonials
    And 99+ others
    Have tried Lucida Clinical Trial
    Lucida